WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma

Glioblastoma (GBM) is a universally fatal brain cancer, for which novel therapies targeting specific underlying oncogenic events are urgently needed. While the WNT pathway has been shown to be frequently activated in GBM, constituting a potential therapeutic target, the relevance of WNT6, an activat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Céline S., Vieira de Castro, Joana, Pojo, Marta, Martins, Eduarda P., Queirós, Sandro, Chautard, Emmanuel, Taipa, Ricardo, Pires, Manuel Melo, Pinto, Afonso A., Pardal, Fernando, Custódia, Carlos, Faria, Cláudia C., Clara, Carlos, Reis, Rui M., Sousa, Nuno, Costa, Bruno M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160775/
https://www.ncbi.nlm.nih.gov/pubmed/30279739
http://dx.doi.org/10.7150/thno.25025

Ejemplares similares

Ejemplares similares